Investors

Roche’s Investor Event at ASCO 2026

Roche has hosted an Investor Event at ASCO on Tuesday, 2 June 2026.

Please click here to watch the replay
Presentation download

Panoramic view of a city skyline against a clear sky, with tall skyscrapers outlined in sunlight, and a calm body of water in the foreground.

Roche’s Virtual ADA Investor Event

Monday, 8 June 2026 at 5:00 PM CEST

More details

A gloved hand in a lab coat holds a small, clear vial against a blurred background of lab equipment, conveying a scientific and clinical setting.

Roche Diagnostics Day 2026

Roche has hosted a Diagnostics Day on Tuesday, 12th May 2026 in London.

Please click here to watch the replay
Presentation download

Investors at a glance

+11%

Core earnings per share growth at Constant Exchange Rates in 2025 (Core EPS 19.46 CHF - diluted)

39 million

patients were treated with Roche medicines in 2025

31 billion

Roche Diagnostic tests were delivered to customers worldwide in 2025

Product Development Pipeline

Read the letter to shareholders

Our two divisions are focusing jointly on three disease areas that will account for almost 50% of the global disease burden by 2035: cancer, cardiovascular-metabolic diseases and neurological diseases.

Dr Thomas Schinecker

CEO Roche Group

Investor updates

View all updates

View ad-hoc announcements

Upcoming Investor events

View all events

Jefferies Global Life Science ConferenceInvestors

June 03, 2026 at 08:00 EDT | New York, US

Add to calendar

BNP Paribas Exane 28th CEO ConferenceInvestors

June 04, 2026 at 08:00 CEST | Paris, FR

Add to calendar

Goldman Sachs 28th Annual Global Healthcare ConferenceInvestors

June 08, 2026 at 08:00 EST | Miami, US

Add to calendar

Roche’s Virtual ADA Investor EventInvestors

June 08, 2026 at 17:00 CEST

Add to calendar

Citi European Healthcare ConferenceInvestors

June 11, 2026 at 08:00 BST | London, UK

Add to calendar

J.P. Morgan European Healthcare ForumInvestors

June 18, 2026 at 08:00 EST | London, UK

Add to calendar

Roche Half Year Results 2026 (virtual event)Investors

July 23, 2026 at 14:00 CEST | Basel, Switzerland

Add to calendar

Roche Pharma Day 2026Investors

September 28, 2026 at 09:00 BST | London UK

Add to calendar

Roche 3rd Quarter Sales 2026 (virtual event)Investors

October 22, 2026 at 14:00 CEST | Basel, Switzerland

Add to calendar

Latest reports

Annual report 2025Investors

Smiling scientist in a lab coat and safety glasses holds a pipette in a modern laboratory. The setting conveys focus and innovation.

Half-year report 2025Investors

Finance Information Tool

Reporting

Download center

Share and Bond information

US investors

ESG Index

Investor relations team contacts

Do you need to get in touch with us? Reach out to our investor relations team with your enquiries.

View investor contact detail

Discover More

Roche Diagnostics news

Follow the most recent updates from our Diagnostics business

Genentech

Genentech has been delivering on the promise of biotechnology for over 35 years.

Sustainability at RocheAbout Roche

At Roche, sustainability means operating with a long-term mindset – ensuring more people can benefit from our science and innovation today without compromising the world they will live in tomorrow.

Positions, policies & downloadsAbout Roche

Download our policies, guidelines, positions and other documents.

Frequently asked questionsInvestors

We answer the Roche investors-related most frequently asked questions

PartneringInnovation

At Roche Partnering, we are passionate about science: yours and ours. Through partnerships, we hope that together we can build a better future with medicines that make a real difference to patients.